COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.

Also called NCT01552187

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 360 participants (planned count) (from the registry)
Sponsor
Maria Vittoria Hospital (from the registry)
Registry
  • NCT NCT01552187
  • EudraCT 2011-005835-21
Other papers using this trial's data
  • Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial JAMA, 2014-09-10 DOI, PubMed 25172965

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01552187. Randomized; quadruple masking; primary purpose prevention. Start 2012-03 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)
Acronym
COPPS-2
Condition
Cardiac Surgery
Condition
Post-pericardiotomy Syndrome
Condition
Pericardial Effusion
Condition
Pleural Effusion
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
Maria Vittoria Hospital (class: other)

Record details

Record id
cardio:ct-nct01552187
Content hash
b5ac96cebf598c1cd09096ee402a77d6a114ba3dc35066028fb800cf9821debf